Page 5 of 8
The Journal of Organic Chemistry
(E)-2-(4-Chlorostyryl)quinoline 3k20: White solid, yield: 76%
(50 mg); H NMR (400 MHz, CDCl3) δ 8.09 (t, J = 8.5 Hz, 2H),
ES+) calcd.for C19H13NSH+ [M + H+] m/z 288.0847, found
288.0851.
1
1
2
3
4
5
6
7.77 (d, J = 8.1 Hz, 1H), 7.70 (t, J = 7.7 Hz, 1H), 7.65 – 7.60 (m,
2H), 7.54 (d, J = 8.2 Hz, 2H), 7.49 (t, J = 7.5 Hz, 1H), 7.37 – 7.33
(m, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ 155.7, 148.4, 136.5,
135.2, 134.4, 133.1, 129.9, 129.6, 129.3, 129.1, 128.5, 127.6,
126.4, 121.0, 119.5.
(E)-6-Chloro-2-styrylquinoline 3r20: White solid, yield: 78% (52
1
mg); H NMR (400 MHz, CDCl3) δ 8.01 – 7.99 (m, 2H), 7.74 –
7.73 (m, 1H), 7.71 – 7.62 (m, 5H), 7.42 – 7.31 (m, 4H). 13C{1H}
NMR (100 MHz, CDCl3) δ 156.3, 146.7, 136.5, 135.5, 135.0,
131.9, 130.9, 130.7, 129.0, 128.9, 128.6, 128.0, 127.4, 126.3,
120.3.
7
8
9
(E)-2-(4-Bromostyryl)quinoline 3l21: White solid, yield: 81%
(63 mg); 1H NMR (400 MHz, CDCl3) δ 8.13 (d, J = 8.6 Hz, 1H),
8.08 (d, J = 8.5 Hz, 1H), 7.78 (d, J = 8.1 Hz, 1H), 7.71 (t, J = 7.7
Hz, 1H), 7.65 – 7.61 (m, 2H), 7.53 – 7.48 (m, 5H), 7.40 – 7.36
(m, 1H).13C{1H} NMR (100 MHz, CDCl3) δ 155.7, 148.4, 136.6,
135.6, 133.3, 132.1, 130.0, 129.7, 129.3, 128.8, 127.7, 127.6,
126.5, 122.7, 119.5.
(E)-6-Bromo-2-styrylquinoline 3s20: White solid, yield: 75% (58
mg); 1H NMR (400 MHz, CDCl3) δ 7.99 (d, J = 8.6 Hz, 1H), 7.94
– 7.91 (m, 2H), 7.75 (dd, J = 8.9, 2.2 Hz, 1H), 7.68 (d, J = 16.3
Hz, 1H), 7.66 – 7.62 (m, 3H), 7.42 – 7.32 (m, 4H). 13C{1H} NMR
(100 MHz, CDCl3) δ 156.4, 146.9, 136.4, 135.4, 135.1, 133.3,
131.0, 129.7, 128.9 (2C), 128.6, 128.5, 127.4.120.3, 120.0.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(E)-2-(2-(Naphthalen-1-yl)vinyl)quinoline 3m10: White solid,
1
yield: 80% (56 mg); H NMR (400 MHz, CDCl3) δ 8.53 (d, J =
(E)-7-Chloro-2-styrylquinoline 3t21: White solid, yield: 83% (55
16.0 Hz, 1H), 8.35 (d, J = 8.3 Hz, 1H), 8.17 – 8.13 (m, 2H), 7.93
– 7.71 (m, 6H), 7.61 – 7.46 (m, 5H). 13C{1H} NMR (100 MHz,
CDCl3) δ 156.2, 148.4, 136.6, 134.2, 133.9, 131.9, 131.6, 131.5,
129.9, 129.4, 129.1, 128.8, 127.7, 127.6, 126.5, 126.4, 126.1,
125.8, 124.3, 123.9, 119.7.
1
mg); H NMR (400 MHz, CDCl3) δ 8.08-8.06 (m, 2H), 7.71 (dd,
J = 7.3, 6.3 Hz, 1H), 7.68 (d, J = 1.6 Hz, 1H), 7.65 – 7.61 (m,
3H), 7.44-7.34 (m, 5H). 13C{1H} NMR (100 MHz, CDCl3) δ
157.0, 148.8, 136.5, 136.2, 135.7, 135.3, 129.0 (2C), 128.8, 128.6,
128.3, 127.5, 127.2, 125.8, 119.8.
(E)-2-(2-(Anthracen-9-yl)vinyl)quinoline 3n: Yellow solid,
1
(E)-2-Styrylpyrazine 5a9: White solid, yield: 81% (40 mg); H
1
yield: 84% (69 mg); H NMR (400 MHz, CDCl3) δ 8.63 (d, J =
NMR (400 MHz, CDCl3) δ 8.65 (d, J = 0.6 Hz, 1H), 8.55 – 8.54
(m, 1H), 8.41 (d, J = 2.4 Hz, 1H), 7.76 (d, J = 16.1 Hz, 1H), 7.60
(d, J = 7.4 Hz, 2H), 7.40 (t, J = 7.4 Hz, 2H), 7.36 – 7.34 (m, 1H),
7.16 (d, J = 16.1 Hz, 1H).13C{1H} NMR (100 MHz, CDCl3) δ
151.4, 144.5, 143.9, 142.9, 136.2, 135.4, 129.2, 129.0, 127.5,
124.2.
16.5 Hz, 1H), 8.45 – 8.43 (m, 2H), 8.32 (dd, J = 5.7, 3.3 Hz, 1H),
8.22 (d, J = 8.4 Hz, 1H), 8.15 (d, J = 8.4 Hz, 1H), 8.05 – 8.03 (m,
2H), 7.86 – 7.84 (m, 1H), 7.81 – 7.74 (m, 3H), 7.57 – 7.55 (m,
1H), 7.51 – 7.48 (m, 3H), 7.29 (dd, J = 16.4 Hz, 1H).13C{1H}
NMR (100 MHz, CDCl3) δ 155.7, 148.5, 137.6, 136.7, 134.3,
133.6, 132.0, 131.6, 131.2, 130.0, 129.8, 129.6, 128.9, 127.7,
127.4, 127.3, 126.5, 126.1, 125.9, 125.4, 119.8. HRMS (TOF MS
ES+) calcd.for C25H17NH+ [M + H+] m/z 332.1439, found
332.1450.
(E)-2-(4-Methylstyryl)pyrazine 5b9: White solid, yield: 75% (37
mg); 1H NMR (400 MHz, CDCl3) δ 8.62 (d, J = 1.4 Hz, 1H), 8.52
– 8.51 (m, 1H), 8.38 (d, J = 2.5 Hz, 1H), 7.72 (d, J = 16.1 Hz,
1H), 7.49 (d, J = 8.1 Hz, 2H), 7.20 (d, J = 8.0 Hz, 2H), 7.10 (d, J
= 16.1 Hz, 1H), 2.37 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ
151.6, 144.4, 143.8, 142.6, 139.3, 135.2, 133.4, 129.7, 127.4,
123.1, 21.5.
(E)-2-(2-(Pyren-1-yl)vinyl)quinoline 3o: Yellow solid, yield:
79% (70 mg); 1H NMR (500 MHz, CDCl3) δ = 8.83 (d, J = 15.9
Hz, 1H), 8.61 (d, J = 9.1 Hz, 1H), 8.45 (d, J = 7.9 Hz, 1H), 8.20 –
8.16 (m, 5H), 8.10 – 8.00 (m, 4H), 7.81 (dd, J = 8.5, 5.5 Hz, 2H),
7.75 (t, J = 7.8 Hz, 1H), 7.66 (d, J = 15.9 Hz, 1H), 7.54 – 7.50 (m,
1H); 13C{1H} NMR (125 MHz, CDCl3) δ 156.2, 148.4, 136.6,
131.7, 131.6, 131.6, 131.4, 131.0, 131.0, 130.0, 129.4, 129.2,
128.1, 127.9, 127.7, 127.6 (2C), 126.4, 126.2, 125.7, 125.4, 125.4,
125.2, 125.0, 124.1, 123.1, 119.8. HRMS (TOF MS ES+)
calcd.for C27H17NH+ [M + H+] m/z 356.1439, found 356.1458.
(E)-2-(2-(Naphthalen-1-yl)vinyl)pyrazine 5c: White solid, yield:
73% (42 mg); 1H NMR (400 MHz, CDCl3) δ 8.69 (s, 1H), 8.62 –
8.59 (m, 2H), 8.45 – 8.44 (m, 1H), 8.30 (d, J = 8.3 Hz, 1H), 7.90
– 7.84 (m, 3H), 7.60 – 7.50 (m, 3H), 7.22 (d, J = 15.7 Hz, 1H).
13C{1H} NMR (100 MHz, CDCl3) δ 151.5, 144.6, 144.1, 143.0,
133.9, 133.8, 132.4, 131.6, 129.5, 128.8, 126.8, 126.6, 126.2,
125.7, 124.3, 123.8. HRMS (TOF MS ES+) calcd.for C16H12N2H+
[M + H+] m/z 233.1079, found 233.1086.
(E)-2-(2-(Thiophen-2-yl)vinyl)quinoline 3p20: White solid,
1
yield: 74% (44 mg); H NMR (400 MHz, CDCl3) δ 8.10 (d, J =
8.6 Hz, 1H), 8.06 (d, J = 8.5 Hz, 1H), 7.84 (d, J = 16.0 Hz, 1H),
7.79 – 7.74 (m, 1H), 7.72 – 7.68 (m, 1H), 7.58 (d, J = 8.6 Hz,
1H), 7.51 – 7.46 (m, 1H), 7.30 – 7.29(m, 1H), 7.24 – 7.19 (m,
2H), 7.06 – 7.04 (m, 1H).13C{1H} NMR (100 MHz, CDCl3) δ
155.7, 148.4, 142.2, 136.5, 129.9, 129.2, 128.3, 128.3, 128.0,
127.6, 127.5, 127.4, 126.3, 126.2, 119.5.
(E)-2-Styrylquinoxaline 5d9: White solid, yield: 84% (49 mg);
1H NMR (400 MHz, CDCl3) δ 9.03 (s, 1H), 8.08– 8.05 (m, 2H),
7.86 (d, J = 16.3 Hz, 1H), 7.77 – 7.73 (m, 1H), 7.71 – 7.64 (m,
3H), 7.44 – 7.34 (m, 4H). 13C{1H} NMR (100 MHz, CDCl3) δ
150.7, 144.5, 142.5, 141.7, 136.5, 136.1, 130.4, 129.4 (2C), 129.3
(2C), 129.0, 127.6, 125.4. HRMS (TOF MS ES+) calcd.for
C16H12N2H+ [M + H+] m/z 233.1079, found 233.1086.
(E)-2-(2-(Benzo[b]thiophen-2-yl)vinyl)quinoline 3q: White
solid, yield: 68% (49 mg); 1H NMR (400 MHz, CDCl3) δ 8.14 (d,
J = 8.6 Hz, 1H), 8.09 (d, J = 8.5 Hz, 1H), 7.96 (d, J = 15.9 Hz,
1H), 7.82 – 7.70 (m, 4H), 7.62 (d, J = 8.6 Hz, 1H), 7.53 – 7.49
(m, 1H), 7.43 (s, 1H), 7.37 – 7.32 (m, 2H), 7.26 (d, J = 15.9 Hz,
1H).13C{1H} NMR (100 MHz, CDCl3) δ 155.3, 148.5, 142.3,
140.2, 139.7, 136.6, 130.8, 130.0, 129.4, 128.0, 127.7, 127.6,
126.5, 125.7, 125.5, 124.8, 124.0, 122.5, 119.9. HRMS (TOF MS
(E)-2-(4-Methylstyryl)quinoxaline 5e: White solid, yield: 72%
(44 mg); 1H NMR (400 MHz, CDCl3) δ 9.02 (s, 1H), 8.07 – 8.04
(m, 2H), 7.84 (d, J = 16.3 Hz, 1H), 7.76 – 7.67 (m, 2H), 7.55 (d,
J = 7.8 Hz, 2H), 7.33 (d, J = 16.3 Hz, 1H), 7.26 – 7.22 (m, 2H),
2.39 (s, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 151.0,
144.6, 142.6, 141.6, 139.6, 136.6, 133.4, 130.4, 129.8, 129.4,
5
ACS Paragon Plus Environment